ABRAMYST Trademark

Trademark Overview


On Monday, February 1, 2016, a trademark application was filed for ABRAMYST with the United States Patent and Trademark Office. The USPTO has given the ABRAMYST trademark a serial number of 86892617. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 10, 2023. This trademark is owned by Glaxo Group Limited. The ABRAMYST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
abramyst

General Information


Serial Number86892617
Word MarkABRAMYST
Filing DateMonday, February 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 10, 2023
Registration Number5031920
Registration DateTuesday, August 30, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Friday, March 10, 2023CANCELLED SEC. 8 (6-YR)
Monday, August 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 1, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 30, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 30, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 5, 2016ASSIGNED TO EXAMINER
Thursday, February 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 4, 2016NEW APPLICATION ENTERED